Abinash Choudhury: A Mother’s Advocacy Transforming Hemophilia Care in Nigeria
Abinash Choudhury, Associate Scientific Writer at Sanofi Global Hub, shared on LinkedIn:
”In Nigeria, undiagnosed bleeding disorders have historically led to deaths that went unrecorded.
For Megan Adediran Founder and Executive Director, Haemophilia Foundation of Nigeria, that reality became personal when her sons were diagnosed with Hemophilia A and the resources simply were not there.
So, she built them.
‘The love of a mother was my only motivation. I just wanted my son[s] to live.’
‘What started as a mother’s fight became the Haemophilia Foundation of Nigeria, directly confronting the systemic barriers that leave so many without access to diagnosis or care.’
This World Hemophilia Day, Megan‘s story reminds us why this year’s theme, ‘Diagnosis, first step to care,’ is a challenge to everyone working across health systems, policy, and advocacy to close the gaps that still exist.
We are proud to partner with the World Federation of Hemophilia to advance equitable, sustainable access to care for people with hemophilia globally.
See how we are working to make that a reality.”
Proceed to the video attached to the post.

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice